Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Explore the atypical signs and symptoms of lung cancer, including the rare paraneoplastic syndromes caused by the disease. Learn about small cell carcinoma’s manifestations like Lambert-Eaton myasthenic syndrome,…
Multiple Myeloma is a cancer that affects plasma cells in bone marrow. Abnormal plasma cells produce harmful proteins, leading to anemia, bone pain, frequent infections, and kidney failure.…
A groundbreaking trial in the UK is testing the world’s first “personalized” mRNA vaccine against the deadliest form of skin cancer, melanoma. This innovative vaccine is tailored to…
This is a comprehensive overview of Chronic Myelogenous Leukemia (CML), a rare type of cancer affecting bone marrow and blood cell development. Arpan Parichha, MD discusses the disease’s…
Abigail Schubach, MD, Gary S. Firestein, MD, and Ellen M. Gravallese, MD discuss the complexities of Rheumatoid Arthritis (RA), an autoimmune condition affecting millions globally. These doctors talk…
Michael Hofman, FRACP, MBBS, explores the evolving landscape of imaging techniques in the diagnosis and treatment of renal cell carcinoma, particularly focusing on PET-CT scans. Historically underutilized in…
Thomas Fox, MBChB, MD, PhD, dives into the complexities of treating primary immunodeficiencies with bone marrow transplants, highlighting the necessity for highly individualized patient assessments. He introduces two…
Visit the fictional town of Deficiency, Maine, where primary immunodeficiencies affecting both B and T cells are explored through a captivating narrative. The scene is set during summer…
Learn about the specifics of treating non-small cell lung cancer (NSCLC) when a KRAS mutation is present. The KRAS gene, often mutated in several cancers including NSCLC, signals…
Ed Overfield shares his personal battle with non-small cell lung cancer, a journey marked by the loss of his mother to the same disease and his own diagnosis…
